231 related articles for article (PubMed ID: 3653773)
21. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
22. The influence of initial residual disease on the outcome of second-look laparotomy in patients with carcinoma of the ovary.
Soeters RP; Bloch B; Dehaeck K; Levin W
Eur J Gynaecol Oncol; 1992; 13(3):223-7. PubMed ID: 1618220
[TBL] [Abstract][Full Text] [Related]
23. Prognosticators of second-look laparotomy findings in patients with epithelial ovarian cancer.
Ayhan A; Yarali H; Develioğlu O; Uren A; Ozyilmaz F
J Surg Oncol; 1991 Apr; 46(4):222-5. PubMed ID: 2008088
[TBL] [Abstract][Full Text] [Related]
24. Second-look laparotomy and salvage therapy: a research modality only?
Potter ME; Hatch KD; Soong SJ; Partridge EE; Austin JM; Shingleton HM
Gynecol Oncol; 1992 Jan; 44(1):3-9. PubMed ID: 1303613
[TBL] [Abstract][Full Text] [Related]
25. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
26. Ovarian epithelial tumors of low malignant potential.
Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
[TBL] [Abstract][Full Text] [Related]
27. Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patients.
de Gramont A; Drolet Y; Varette C; Louvet C; Gonzalez-Canall G; Krulik M; Cady J; Pigne A; Marpeau L; Barrat J
Eur J Cancer Clin Oncol; 1989 Mar; 25(3):451-7. PubMed ID: 2702999
[TBL] [Abstract][Full Text] [Related]
28. Relationship between peritoneal washing cytology through implantable port system (IPS-cytology) and second-look laparotomy in ovarian cancer patients with unmeasurable residual diseases.
Fujiwara K; Yamauchi H; Yoshida T; Suzuki S; Oda T; Kohno I
Gynecol Oncol; 1998 Aug; 70(2):231-5. PubMed ID: 9740696
[TBL] [Abstract][Full Text] [Related]
29. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic versus therapeutic second-look surgery in patients with ovarian cancer.
Janisch H; Schieder K; Koelbl H
Baillieres Clin Obstet Gynaecol; 1989 Mar; 3(1):191-200. PubMed ID: 2661093
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
32. [The second-look operation in advanced ovarian cancer--experiences since the introduction of cisplatin combination chemotherapy].
Kaufmann M; Hanke J; Schmid H; Kühn W; Kubli F
Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):581-7. PubMed ID: 3770408
[TBL] [Abstract][Full Text] [Related]
33. Stage III-IV epithelial carcinoma of the ovary: is the second-look operation of any value for the patient?
Atad J; Bornstein J; Steiner M; Weill S; Lurie M; Abramovici H
Isr J Med Sci; 1988 Nov; 24(11):660-3. PubMed ID: 3215758
[TBL] [Abstract][Full Text] [Related]
34. Effective multimodality treatment of epithelial ovarian tumors.
Yoonessi M; Crickard K; Crickard U; Butler C; Yoonessi S
Eur J Gynaecol Oncol; 1988; 9(1):13-6. PubMed ID: 3345777
[TBL] [Abstract][Full Text] [Related]
35. Second look laparotomy in the management of malignant epithelial ovarian neoplasias.
Facchini V; Gadducci A; Del Bravo B; Colombi L; Bartolini T; Manfredini C; Fioretti P
Eur J Gynaecol Oncol; 1986; 7(2):122-9. PubMed ID: 3459658
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Results after second-look laparotomy.
Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
Oncology; 1990; 47(2):109-11. PubMed ID: 2314822
[TBL] [Abstract][Full Text] [Related]
37. Second-look laparotomy in the management of patients after radical surgery for ovarian cancer.
Tuxen MK; Lund B; Hansen OP; Hansen M
Ann Oncol; 1993 Feb; 4(2):169-71. PubMed ID: 8448085
[TBL] [Abstract][Full Text] [Related]
38. A critical reassessment of second-look laparotomy in epithelial ovarian carcinoma.
Miller DS; Ballon SC; Teng NN; Seifer DB; Soriero OM
Cancer; 1986 Feb; 57(3):530-5. PubMed ID: 3942985
[TBL] [Abstract][Full Text] [Related]
39. Role of second look laparotomy in multidisciplinary treatment and in the follow up of advanced ovarian cancer.
Maggino T; Tredese F; Valente S; Marchesoni D; Brandes A; Menighetti M; Onnis GL
Eur J Gynaecol Oncol; 1983; 4(1):26-9. PubMed ID: 6861774
[TBL] [Abstract][Full Text] [Related]
40. [The second-look operation in advanced ovarian cancer].
Richter P; Lotze W
Zentralbl Gynakol; 1987; 109(4):228-34. PubMed ID: 2438864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
